Enlimomab - CAS 142864-19-5

Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody targeting human ICAM-1, reduces leukocyte adhesion to the vascular endothelium, diminishing leukocyte extravasation and inflammatory tissue damage; it exhibits anti-inflammatory properties and is utilized in stroke research [1] [2].

Integrin

Cytoskeletal Signaling

142840

-20°C

Ice Packs

Inhibitory Antibodies